Deceased donor risk factors influencing liver transplant outcome

Transplant International

Volumn 26, Issue 5, 2013, Pages 463-470

  Freeman, Richard B ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

cardiac death; deceased donors; donor pool; liver transplantation; outcome

Indexed keywords

AGE; CAUSE OF DEATH; DELAYED GRAFT FUNCTION; DEMOGRAPHY; GRAFT RECIPIENT; GRAFT SURVIVAL; HOSPITAL COST; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

CADAVER; CONTINENTAL POPULATION GROUPS; DELAYED GRAFT FUNCTION; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; OBESITY; ORGAN SIZE; RISK FACTORS; SEXISM; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84876467655     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12071     Document Type: Review

References (74)

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011. http://www.srtr.org/annual-reports/2010/910a-donagecat-li.htm (Accessed 10 October 2012).
2. European Liver Transplant Registry. www.eltr.org/spip.php?article156 (Accessed 10 October 2012).
3. Sampedro B, Cabezas J, Fábrega E, Casafont F, Pons-Romero F,. Liver transplantation with donorsolder than 75 years. Transplant Proc 2011; 43: 679.
4. Emre S, Schwartz ME, Altaca G, et al,. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996; 62: 62.
5. Nardo B, Masetti M, Urbani L, et al,. Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant 2004; 4: 1139.
6. Angelico M, Cillo U, Fagiuoli S, et al,. Liver Match Investigators. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis 2011; 43: 155.
7. Jay C, Ladner D, Wang E, et al,. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant-an analysis of the national registry. J Hepatol 2011; 55: 808.
8. Fukumori T, Kato T, Levi D, et al,. Use of older controlled non-heart-beating donors for liver transplantation. Transplantation 2003; 75: 1171.
9. Berenguer M, Prieto M, San Juan F, et al,. Contribution of donorage to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202.
10. Uemura T, Nikkel LE, Hollenbeak CS, Ramprasad V, Schaefer E, Kadry Z,. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C? Transpl Int 2012; 25: 671.
11. Uemura T, Ramprasad V, Hollenbeak CS, Bezinover D, Kadry Z,. Liver transplantation for hepatitis C from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J of Transplant 2012; 12: 984.
12. Selzner M, Kashfi A, Selzner N, et al,. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation. Liver Transpl 2009; 15: 1288.
13. Marino IR, Doyle HR, Aldrighetti L, et al,. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22: 1754.
14. Goh A,. An analysis of liver transplant survival rates from the UNOS registry. Clin Transpl 2008; 19.
15. Ioannou GN,. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006; 12: 1594.
16. Sanfey H,. Gender-specific issues in liver and kidney failure and transplantation: a review. J Womens Health (Larchmt) 2005; 14: 617.
17. Feng S, Goodrich NP, Bragg-Gresham JL, et al,. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
18. Mallik M, Callaghan CJ, Hope M, et al,. Comparison of liver transplantation outcomes from adult split liver and circulatory death donors. Br J Surg 2012; 99: 839.
19. Colombani PM, Cigarroa FG, Schwarz K, Wise B, Maley WE, Klein AS,. Liver transplantation in infants younger than 1 year of age. Ann Surg 1996; 223: 658.
20. Pang PS, Kamal A, Glenn JS,. Effect of donor race on the survival of black Americans undergoing liver transplantation for chronic hepatitis C. Liver Transpl 2009; 15: 1126.
21. Cintorino D, Spada M, Gruttadauria S, et al,. In situ split liver transplantation for adult and pediatric recipients: an answer to organ shortage. Transplant Proc 2006; 38: 1096.
22. Yersiz H, Renz JF, Farmer DG, Hisatake GM, McDiarmid SV, Busuttil RW,. One hundred in situ split-liver transplantations: a single-center experience. Ann Surg 2003; 238: 496.
23. Sandroussi C, Crawford M, Lockwood DS, et al,. Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients. Liver Transpl 2009; 15: 1586.
24. Zambelli M, Andorno E, De Carlis L, et al,. Full-right-full-left split liver transplantation: the retrospective analysis of an early multicenter experience including graft sharing. Am J Transplant 2012; 12: 2198.
25. Hong JC, Yersiz H, Busuttil RW,. Where are we today in split liver transplantation? Curr Opin Organ Transplant 2011; 16: 269.
26. Yoo HY, Molmenti E, Thuluvath PJ,. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transpl 2003; 9: 72.
27. Perito ER, Rhee S, Glidden D, Roberts JP, Rosenthal P,. Impact of the donor body mass index on the survival of pediatric recipients and post transplant obesity. Liver Transpl 2012; 18: 930.
28. Selzner M, Clavien PA,. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105.
29. Marsman WA, Wiesner RH, Rodriguez L, et al,. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 1246.
30. de Graaf EL, Kench J, Dilworth P, et al,. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol 2012; 27: 540.
31. Doyle MB, Vachharajani N, Wellen JR, et al,. Short- and long-term outcomes after steatotic liver transplantation. Arch Surg 2010; 145: 653.
32. Spitzer AL, Lao OB, Dick AA, et al,. The biopsied donorliver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010; 16: 874.
33. Biesterfeld S, Knapp J, Bittinger F, Götte H, Schramm M, Otto G,. Frozen section diagnosis in donorliver biopsies: observer variation of semiquantitative and quantitative steatosis assessment. Virchows Arch 2012; 461: 177.
34. Freeman RB Jr,. The 'indirect' effects of cytomegalovirus infection. Am J Transplant 2009; 9: 2453.
35. Cao S, Cox KL,. Epstein-Barr virus lymphoproliferative disorders after liver transplantation. Clin Liver Dis 1997; 1: 453.
36. Fernández MC, Bes D, De Dávila M, Lõpez S, Cambaceres C, Dip M,. Imventarza O Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome. Pediatr Transplant 2009; 13: 307.
37. Bellandi T, Albolino S, Tartaglia R, Filipponi F,. Unintended transplantation of three organs from an HIV-positive donor: report of the analysis of an adverse event in a regional health care service in Italy. Transplant Proc 2010; 42: 2187.
38. Centers for Disease Control and Prevention (CDC). Brief report: Lymphocytic choriomeningitis virus transmitted through solid organ transplantation-Massachusetts, 2008. MMWR Morb Mortal Wkly Rep 2008; 57: 799.
39. Angelis M, Cooper JT, Freeman RB,. Impact of donor infections on outcome of orthotopic liver transplantation. Liver Transpl 2003; 9: 451.
40. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW,. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation 2007; 84: 272.
41. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994; 43: 1.
42. Saab S, Ghobrial RM, Ibrahim AB, et al,. Hepatitis C positive graft may be used in orthotopic liver transplantation: a matched analysis. Am J Transplant 2003; 3: 1167.
43. Vargas HE, Laskut T, Wang LF, et al,. Outcome of liver transplantation in hepatitis C virus infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999; 117: 149.
44. Loggi E, Micco L, Ercolani G, et al,. Andreone P liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. J Hepatol 2012; 56: 579.
45. MacConmara MP, Vachharajani N, Wellen JR, et al,. Utilization of hepatitis B core antibody-positive donor liver grafts. HPB (Oxford) 2012; 14: 42.
46. Lai JC, Feng S, Roberts JP,. An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology 2012; 143: 1261.
47. Fitzgerald RD, Dechtyar I, Templ E, Pernerstorfer T, Hackl W, Lackner FX,. Endocrine stress reaction to surgery in brain-dead organ donors. Transpl Int 1996; 9: 102.
48. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011. http://www.srtr.org/annual-reports/2010/910a-donagecat-li.htm (Accessed 10 October 2012).
49. Saidi RF, Bradley J, Greer D, et al,. Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transpl 2010; 10: 2536.
50. Monbaliu D, Pirenne J, Talbot D,. Liver transplantation using donation after cardiac death donors. J Hepatol 2012; 56: 474.
51. Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR,. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006; 82: 1683.
52. Ho KJ, Owens CD, Johnson SR, et al,. Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation 2008; 85: 1588.
53. DeOliveira ML, Jassem W, Valente R, et al,. Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center. Ann Surg 2011; 254: 716.
54. Rhee JY, Alroy J, Freeman RB,. Characterization of the withdrawal phase in a porcine donation after the cardiac death model. Am J Transplant 2011; 11: 1169.
55. Taner CB, Bulatao IG, Willingham DL, et al,. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl 2012; 18: 101.
56. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM,. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transpl 2010; 10: 2512.
57. Taner BC, Bulatao IG, Perry DK, et al,. Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors. Transplant Int 2012; 25: 838.
58. Foley DP, Fernandez LA, Leverson G, et al,. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term out- comes from a single center. Ann Surg 2011; 253: 817.
59. Hashimoto K, Eghtesad B, Gunasekaran G, et al,. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transpl 2010; 10: 2665.
60. Fondevila C, Hessheimer AJ, Ruiz A, et al,. Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant 2007; 7: 1849.
61. Ozhathil DK, Li Y, Smith JK, et al,. Effect of centre volume and high donor risk index on liver allograft survival. HPB (Oxford) 2011; 13: 447.
62. Lai JC, Roberts JP, Vittinghoff E, Terrault NA, Feng S,. Patient center and geographic characteristics of nationally placed livers. Am J Transplant 2012; 12: 947.
63. Harring TR, Nguyen NT, Cotton RT, et al,. Liver transplantation with donation after cardiac death donors: a comprehensive update. J Surg Res 2012; 178: 502.
64. Hong JC, Yersiz H, Kositamongkol P, et al,. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg 2011; 146: 1017.
65. Sotiropoulos GC, Paul A, Gerling T, et al,. Liver transplantation with "rescue organ offers" within the eurotransplant area: a 2-year report from the University Hospital Essen. Transplantation 2006; 82: 304.
66. Porrett PM, Ter Horst M, Shaked A,. Donor assessment scores: relevance and complete irrelevance. Liver Transpl 2012; 18 (Suppl. 2): S25.
67. Schrem H, Reichert B, Frühauf N, et al,. The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity. Ann Transplant 2012; 17: 5.
68. Maluf DG, Edwards EB, Stravitz RT, Kauffman HM,. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients. Liver Transpl 2009; 15: 592.
69. Schaubel DE, Guidinger MK, Biggins SW, et al,. Survival benefit- based deceased-donor liver allocation. Am J Transplant 2009; 9: 970.
70. Braat AE, Blok JJ, Putter H, et al,. The Eurotransplant DonorRisk Index in Liver Transplantation: ET-DRI; for the European Liver and Intestine Transplant Association (ELITA) and Eurotransplant Liver Intestine Advisory Committee (ELIAC). Am J Transplant 2012; 12: 2789.
71. Vitale A, Ramirez Morales R, dalla Bona E, et al,. Donor-model for end-stage liver disease and donor-recipient matching in liver transplantation. Transplant Proc 2011; 43: 974.
72. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD,. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009; 9: 318.
73. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM,. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419.
74. Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM,. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007; 7: 990.